Human Dendritic Cells Express the Complement Receptor Immunoglobulin Which Regulates T Cell Responses

Area of Science:

• Immunology
• Cell Biology

Background:

• Complement Immunoglobulin Receptor (CRIg) is a recently identified complement receptor with distinct properties.
• Previously, CRIg was thought to be exclusively expressed on macrophages.

Purpose of the Study:

• To investigate the expression and function of CRIg in human monocyte-derived dendritic cells (MDDC).
• To explore the role of CRIg in adaptive immunity and T cell responses.

Main Methods:

• Detection of CRIg transcripts and protein forms in MDDC.
• Analysis of CRIg expression regulation by cytokines and dexamethasone.
• Co-culture experiments to assess the impact of CRIg-expressing MDDC on T cell proliferation and cytokine production.

Main Results:

• CRIg is expressed on human MDDC, with multiple transcript and protein forms identified.
• Dexamethasone significantly upregulates CRIg on MDDC, leading to inhibition of T cell proliferation.
• Suppression of T cell responses by dexamethasone-treated MDDC was partially reversible with an anti-CRIg antibody.

Conclusions:

• CRIg expression on dendritic cells suggests a role in adaptive immunity.
• CRIg may serve as a regulatory point for immune responses, influenced by drugs like dexamethasone.
• Targeting CRIg could modulate dendritic cell function and T cell-mediated immunity.